Since HPV appears to have a causative role in the pathogenesis of bladder cancer and p16, p53, and p63 expression are reported to be involved in tumor development and progression, this study aimed to assess ML signature-related SCC of the bladder using clinicopathological outcome data. Here, TP53 is linked to urinary bladder carcinoma.